Sartorius Stedim Biotech Investor Relations
Reference Document 2014
Facts & Figures
Download a brief overview of Sartorius Stedim Biotech and its current economic development.
Expands GE’s start-to-finish offering for cost efficient manufacture of biopharmaceuticals | Increases global access to SSB’s innovative purification technologyDate 01.09.2015 Category Sartorius Stedim Biotech